GlassScriptPhysician profile
Hyunwoo DO
NPI 1669601233
$9,812.26
in general payments reported to CMS, 2019-2025
12 companies · $4,559 in 2025
The $4,559 reported for 2025 was more than what 79% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,486 · 2020: $15.52 · 2021: $304 · 2022: $2,007 · 2023: $799 · 2024: $640 · 2025: $4,559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,471 · Food and Beverage: $2,528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,471.08 |
| Food and Beverage | $2,527.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,583.32 | 2021-2025 | Cd Horizon Spinal System, Mazor X System, Unid_pass |
| Globus Medical, INC. | $2,854.30 | 2019-2025 | Modulus, Acp, Coalition Agx / Agx Rp |
| Abbott Laboratories | $458.59 | 2022-2025 | Eterna |
| Circinus Medical Technology LLC | $255.89 | 2025 | Bolt Navigation |
| Stryker Corporation | $251.45 | 2019-2025 | N/A, Core, Sonopet Iq |
| Boston Scientific Corporation | $122.51 | 2025 | General - Pain Management |
| Elite Orthopedics, LLC | $88.41 | 2024-2025 | |
| Medtronic USA, INC. | $71.08 | 2019-2020 | |
| Bioventus LLC | $59.59 | 2019 | |
| Amplify Surgical, INC. | $35.69 | 2021 | |
| Zimmer Biomet Holdings, INC. | $18.96 | 2025 | Thinflap |
| Abbvie INC. | $12.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hyunwoo DO listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.